お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はコンピテントセル市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはコンピテントセルの主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のコンピテントセル市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはコンピテントセルのメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にコンピテントセル市場を分類しています。本研究に含まれる主な企業は：Merck KGaA、Thermo Fisher Scientific、Agilent Technologies、Takara Bio、Promega Corporation、Beijing TransGen Biotech、GeneScript Corporation、Yeastern Biotech、New England Biolabs、QIAGEN N.V.、OriGene Technologies、Lucigen、Zymo Research、Bio-Rad Laboratories、Bioline、Delphi Genetics、IBA GmBH、Cell Applications、BioDynamics Laboratory、Scarab Genomics、GCC Biotech、SMOBIO Technology、Edge BioSystems

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Chemically Competent Cells
    Electrocompetent Cells

用途別の市場セグメント：
    Subcloning & Routine Cloning
    Phage Display Library Construction
    Toxic/Unstable DNA Cloning
    High-Throughput Cloning
    Protein Expression
    Mutagenesis
    Single-Stranded DNA Production
    Bacmid Creation
    Cre-Lox Recombination (PIR1/PIR2)

本レポートの詳細内容
世界のコンピテントセル市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、コンピテントセルタイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のコンピテントセル収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のコンピテントセル市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、コンピテントセル市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

コンピテントセルのレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：コンピテントセルのレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：コンピテントセルの世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章コンピテントセル企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：コンピテントセルの各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：コンピテントセルの主要企業の概要を提供し、製品の説明と仕様、コンピテントセルの収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Market Analysis and Insights: Global Competent Cells Market
The global Competent Cells market is projected to grow from US$ 2194 million in 2024 to US$ 3782 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.5% during the forecast period.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent. 
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
Report Covers:
This report presents an overview of global market for Competent Cells market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Competent Cells, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Competent Cells, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Competent Cells revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Competent Cells market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Competent Cells revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Merck KGaA
    Thermo Fisher Scientific
    Agilent Technologies
    Takara Bio
    Promega Corporation
    Beijing TransGen Biotech
    GeneScript Corporation
    Yeastern Biotech
    New England Biolabs
    QIAGEN N.V.
    OriGene Technologies
    Lucigen
    Zymo Research
    Bio-Rad Laboratories
    Bioline
    Delphi Genetics
    IBA GmBH
    Cell Applications
    BioDynamics Laboratory
    Scarab Genomics
    GCC Biotech
    SMOBIO Technology
    Edge BioSystems

Segment by Type
    Chemically Competent Cells
    Electrocompetent Cells

Segment by Application
    Subcloning & Routine Cloning
    Phage Display Library Construction
    Toxic/Unstable DNA Cloning
    High-Throughput Cloning
    Protein Expression
    Mutagenesis
    Single-Stranded DNA Production
    Bacmid Creation
    Cre-Lox Recombination (PIR1/PIR2)

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Competent Cells in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Competent Cells companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Competent Cells revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Competent Cells Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Chemically Competent Cells
    Table 3. Key Players of Electrocompetent Cells
    Table 4. Global Competent Cells Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Competent Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Competent Cells Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Competent Cells Market Share by Region (2019-2024)
    Table 8. Global Competent Cells Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Competent Cells Market Share by Region (2025-2030)
    Table 10. Competent Cells Market Trends
    Table 11. Competent Cells Market Drivers
    Table 12. Competent Cells Market Challenges
    Table 13. Competent Cells Market Restraints
    Table 14. Global Competent Cells Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Competent Cells Revenue Share by Players (2019-2024)
    Table 16. Global Top Competent Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2023)
    Table 17. Global Competent Cells Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Competent Cells Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Competent Cells, Headquarters and Area Served
    Table 20. Global Key Players of Competent Cells, Product and Application
    Table 21. Global Key Players of Competent Cells, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Competent Cells Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Competent Cells Revenue Market Share by Type (2019-2024)
    Table 25. Global Competent Cells Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Competent Cells Revenue Market Share by Type (2025-2030)
    Table 27. Global Competent Cells Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Competent Cells Revenue Share by Application (2019-2024)
    Table 29. Global Competent Cells Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Competent Cells Revenue Share by Application (2025-2030)
    Table 31. North America Competent Cells Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Competent Cells Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Competent Cells Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Competent Cells Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Competent Cells Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Competent Cells Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Competent Cells Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Competent Cells Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Competent Cells Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Competent Cells Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Competent Cells Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Competent Cells Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Competent Cells Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Competent Cells Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Competent Cells Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Competent Cells Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Competent Cells Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Competent Cells Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Competent Cells Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Competent Cells Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Competent Cells Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Competent Cells Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Competent Cells Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Competent Cells Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Competent Cells Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Competent Cells Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Competent Cells Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Competent Cells Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Competent Cells Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Competent Cells Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Competent Cells Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Competent Cells Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Merck KGaA Company Details
    Table 64. Merck KGaA Business Overview
    Table 65. Merck KGaA Competent Cells Product
    Table 66. Merck KGaA Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 67. Merck KGaA Recent Developments
    Table 68. Thermo Fisher Scientific Company Details
    Table 69. Thermo Fisher Scientific Business Overview
    Table 70. Thermo Fisher Scientific Competent Cells Product
    Table 71. Thermo Fisher Scientific Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 72. Thermo Fisher Scientific Recent Developments
    Table 73. Agilent Technologies Company Details
    Table 74. Agilent Technologies Business Overview
    Table 75. Agilent Technologies Competent Cells Product
    Table 76. Agilent Technologies Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 77. Agilent Technologies Recent Developments
    Table 78. Takara Bio Company Details
    Table 79. Takara Bio Business Overview
    Table 80. Takara Bio Competent Cells Product
    Table 81. Takara Bio Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 82. Takara Bio Recent Developments
    Table 83. Promega Corporation Company Details
    Table 84. Promega Corporation Business Overview
    Table 85. Promega Corporation Competent Cells Product
    Table 86. Promega Corporation Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 87. Promega Corporation Recent Developments
    Table 88. Beijing TransGen Biotech Company Details
    Table 89. Beijing TransGen Biotech Business Overview
    Table 90. Beijing TransGen Biotech Competent Cells Product
    Table 91. Beijing TransGen Biotech Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 92. Beijing TransGen Biotech Recent Developments
    Table 93. GeneScript Corporation Company Details
    Table 94. GeneScript Corporation Business Overview
    Table 95. GeneScript Corporation Competent Cells Product
    Table 96. GeneScript Corporation Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 97. GeneScript Corporation Recent Developments
    Table 98. Yeastern Biotech Company Details
    Table 99. Yeastern Biotech Business Overview
    Table 100. Yeastern Biotech Competent Cells Product
    Table 101. Yeastern Biotech Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 102. Yeastern Biotech Recent Developments
    Table 103. New England Biolabs Company Details
    Table 104. New England Biolabs Business Overview
    Table 105. New England Biolabs Competent Cells Product
    Table 106. New England Biolabs Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 107. New England Biolabs Recent Developments
    Table 108. QIAGEN N.V. Company Details
    Table 109. QIAGEN N.V. Business Overview
    Table 110. QIAGEN N.V. Competent Cells Product
    Table 111. QIAGEN N.V. Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 112. QIAGEN N.V. Recent Developments
    Table 113. OriGene Technologies Company Details
    Table 114. OriGene Technologies Business Overview
    Table 115. OriGene Technologies Competent Cells Product
    Table 116. OriGene Technologies Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 117. OriGene Technologies Recent Developments
    Table 118. Lucigen Company Details
    Table 119. Lucigen Business Overview
    Table 120. Lucigen Competent Cells Product
    Table 121. Lucigen Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 122. Lucigen Recent Developments
    Table 123. Zymo Research Company Details
    Table 124. Zymo Research Business Overview
    Table 125. Zymo Research Competent Cells Product
    Table 126. Zymo Research Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 127. Zymo Research Recent Developments
    Table 128. Bio-Rad Laboratories Company Details
    Table 129. Bio-Rad Laboratories Business Overview
    Table 130. Bio-Rad Laboratories Competent Cells Product
    Table 131. Bio-Rad Laboratories Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 132. Bio-Rad Laboratories Recent Developments
    Table 133. Bioline Company Details
    Table 134. Bioline Business Overview
    Table 135. Bioline Competent Cells Product
    Table 136. Bioline Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 137. Bioline Recent Developments
    Table 138. Delphi Genetics Company Details
    Table 139. Delphi Genetics Business Overview
    Table 140. Delphi Genetics Competent Cells Product
    Table 141. Delphi Genetics Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 142. Delphi Genetics Recent Developments
    Table 143. IBA GmBH Company Details
    Table 144. IBA GmBH Business Overview
    Table 145. IBA GmBH Competent Cells Product
    Table 146. IBA GmBH Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 147. IBA GmBH Recent Developments
    Table 148. Cell Applications Company Details
    Table 149. Cell Applications Business Overview
    Table 150. Cell Applications Competent Cells Product
    Table 151. Cell Applications Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 152. Cell Applications Recent Developments
    Table 153. BioDynamics Laboratory Company Details
    Table 154. BioDynamics Laboratory Business Overview
    Table 155. BioDynamics Laboratory Competent Cells Product
    Table 156. BioDynamics Laboratory Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 157. BioDynamics Laboratory Recent Developments
    Table 158. Scarab Genomics Company Details
    Table 159. Scarab Genomics Business Overview
    Table 160. Scarab Genomics Competent Cells Product
    Table 161. Scarab Genomics Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 162. Scarab Genomics Recent Developments
    Table 163. GCC Biotech Company Details
    Table 164. GCC Biotech Business Overview
    Table 165. GCC Biotech Competent Cells Product
    Table 166. GCC Biotech Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 167. GCC Biotech Recent Developments
    Table 168. SMOBIO Technology Company Details
    Table 169. SMOBIO Technology Business Overview
    Table 170. SMOBIO Technology Competent Cells Product
    Table 171. SMOBIO Technology Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 172. SMOBIO Technology Recent Developments
    Table 173. Edge BioSystems Company Details
    Table 174. Edge BioSystems Business Overview
    Table 175. Edge BioSystems Competent Cells Product
    Table 176. Edge BioSystems Revenue in Competent Cells Business (2019-2024) & (US$ Million)
    Table 177. Edge BioSystems Recent Developments
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Competent Cells Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Competent Cells Market Share by Type: 2023 VS 2030
    Figure 3. Chemically Competent Cells Features
    Figure 4. Electrocompetent Cells Features
    Figure 5. Global Competent Cells Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Competent Cells Market Share by Application: 2023 VS 2030
    Figure 7. Subcloning & Routine Cloning Case Studies
    Figure 8. Phage Display Library Construction Case Studies
    Figure 9. Toxic/Unstable DNA Cloning Case Studies
    Figure 10. High-Throughput Cloning Case Studies
    Figure 11. Protein Expression Case Studies
    Figure 12. Mutagenesis Case Studies
    Figure 13. Single-Stranded DNA Production Case Studies
    Figure 14. Bacmid Creation Case Studies
    Figure 15. Cre-Lox Recombination (PIR1/PIR2) Case Studies
    Figure 16. Competent Cells Report Years Considered
    Figure 17. Global Competent Cells Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 18. Global Competent Cells Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Competent Cells Market Share by Region: 2023 VS 2030
    Figure 20. Global Competent Cells Market Share by Players in 2023
    Figure 21. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2023)
    Figure 22. The Top 10 and 5 Players Market Share by Competent Cells Revenue in 2023
    Figure 23. North America Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. North America Competent Cells Market Share by Type (2019-2030)
    Figure 25. North America Competent Cells Market Share by Application (2019-2030)
    Figure 26. North America Competent Cells Market Share by Country (2019-2030)
    Figure 27. United States Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Canada Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Europe Competent Cells Market Size YoY (2019-2030) & (US$ Million)
    Figure 30. Europe Competent Cells Market Share by Type (2019-2030)
    Figure 31. Europe Competent Cells Market Share by Application (2019-2030)
    Figure 32. Europe Competent Cells Market Share by Country (2019-2030)
    Figure 33. Germany Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. France Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. U.K. Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Italy Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Russia Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Nordic Countries Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. China Competent Cells Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. China Competent Cells Market Share by Type (2019-2030)
    Figure 41. China Competent Cells Market Share by Application (2019-2030)
    Figure 42. Asia Competent Cells Market Size YoY (2019-2030) & (US$ Million)
    Figure 43. Asia Competent Cells Market Share by Type (2019-2030)
    Figure 44. Asia Competent Cells Market Share by Application (2019-2030)
    Figure 45. Asia Competent Cells Market Share by Region (2019-2030)
    Figure 46. Japan Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. South Korea Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. China Taiwan Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. India Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Australia Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Competent Cells Market Size YoY (2019-2030) & (US$ Million)
    Figure 53. Middle East, Africa, and Latin America Competent Cells Market Share by Type (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Competent Cells Market Share by Application (2019-2030)
    Figure 55. Middle East, Africa, and Latin America Competent Cells Market Share by Country (2019-2030)
    Figure 56. Brazil Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Mexico Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Turkey Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Saudi Arabia Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Israel Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. GCC Countries Competent Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. Merck KGaA Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 64. Agilent Technologies Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 65. Takara Bio Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 66. Promega Corporation Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 67. Beijing TransGen Biotech Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 68. GeneScript Corporation Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 69. Yeastern Biotech Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 70. New England Biolabs Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 71. QIAGEN N.V. Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 72. OriGene Technologies Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 73. Lucigen Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 74. Zymo Research Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 75. Bio-Rad Laboratories Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 76. Bioline Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 77. Delphi Genetics Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 78. IBA GmBH Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 79. Cell Applications Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 80. BioDynamics Laboratory Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 81. Scarab Genomics Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 82. GCC Biotech Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 83. SMOBIO Technology Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 84. Edge BioSystems Revenue Growth Rate in Competent Cells Business (2019-2024)
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed